GlassScriptPhysician profile
Mathew T Chengot
NPI 1831147511
$20,337.00
in general payments reported to CMS, 2019-2025
55 companies · $2,586 in 2025
The $2,586 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,675 · 2020: $2,317 · 2021: $2,103 · 2022: $2,555 · 2023: $2,731 · 2024: $3,370 · 2025: $2,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,499 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,499.49 |
| Education | $187.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,735.13 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $1,646.96 | 2019-2024 | Xarelto |
| Abbott Laboratories | $1,554.49 | 2019-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Novartis Pharmaceuticals Corporation | $1,256.04 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,048.77 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $776.67 | 2019-2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $774.41 | 2019-2025 | Farxiga, Wainua, Lynparza |
| Amgen INC. | $746.58 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $742.79 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $723.90 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $691.88 | 2019-2025 | Watchman Flx, Watchman Access System |
| Medicomp INC | $607.38 | 2022-2025 | Telepatch Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $595.78 | 2019-2025 | Lifevest |
| Pfizer INC. | $593.91 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $591.21 | 2022-2025 | Verquvo, Capvaxive |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $558.16 | 2023-2025 | Barostim Neo System |
| Medtronic, INC. | $542.88 | 2022-2025 | Linq II, Onyx Frontier, Aurora Ev-Icd Mri Surescan |
| Bayer Healthcare Pharmaceuticals INC. | $475.46 | 2019-2025 | |
| Esperion Therapeutics, INC. | $428.91 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $398.01 | 2019-2022 | |
| Biotronik INC. | $311.23 | 2019-2021 | |
| Intra-Sana Laboratories | $296.85 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Amarin Pharma, INC. | $293.95 | 2020-2021 | |
| Edwards Lifesciences Corporation | $289.38 | 2021-2025 | Sapien 3 Ultra Resilia |
| Daiichi Sankyo INC. | $237.72 | 2022-2024 | Injectafer |
| Inari Medical, INC. | $220.98 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $182.12 | 2023 | Arcalyst |
| Lundbeck LLC | $164.27 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $141.71 | 2019-2024 | Livalo |
| Abiomed | $129.83 | 2025 | |
| Arbor Pharmaceuticals, INC. | $129.00 | 2019-2021 | |
| Tactile Systems Technology INC | $121.95 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Corium, LLC | $118.39 | 2023 | Adlarity |
| Artivion, INC. | $117.94 | 2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cryovalve Sg Pulmonary Human Heart Valve |
| Regeneron Healthcare Solutions, INC. | $116.93 | 2019-2025 | Evkeeza |
| Progenics Pharmaceuticals, INC. | $114.58 | 2023 | Pylarify |
| Bardy Diagnostics, INC. | $110.85 | 2020-2022 | |
| Irhythm Technologies, INC. | $93.03 | 2023 | Zio Xt Patch |
| Philips North America LLC | $84.18 | 2025 | Mcot |
| Heartflow, INC. | $80.80 | 2022-2024 | Ffrct |
| Lilly USA, LLC | $62.48 | 2025 | Jardiance, Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $60.74 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $45.38 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $44.21 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $42.11 | 2025 | Attruby |
| Gilead Sciences, INC. | $38.33 | 2019 | |
| Baxter Healthcare | $27.89 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| 180 Medical, INC. | $26.35 | 2025 | Juzo Compression Wrap |
| Vanda Pharmaceuticals INC. | $25.03 | 2024 | Ponvory |
| Kestra Medical Technology Services, INC. | $24.40 | 2022 | |
| Ionis Pharmaceuticals, INC. | $21.84 | 2025 | Tryngolza |
| Acorda Therapeutics, INC | $20.55 | 2024 | Inbrija |
| Glaxosmithkline, LLC. | $19.30 | 2025 | Shingrix, Arexvy |
| Alexion Pharmaceuticals, INC. | $18.34 | 2024 | Ultomiris |
| Dexcom, INC. | $15.04 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Chengot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.